A new trading day began on Monday, with Codexis Inc (NASDAQ: CDXS) stock price down -7.11% from the previous day of trading, before settling in for the closing price of $2.88. CDXS’s price has ranged from $1.90 to $6.08 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -33.31%. Meanwhile, its annual earnings per share averaged 26.16%. With a float of $87.50 million, this company’s outstanding shares have now reached $90.25 million.
Let’s determine the extent of company efficiency that accounts for 188 employees.
Codexis Inc (CDXS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Codexis Inc is 3.07%, while institutional ownership is 79.85%. The most recent insider transaction that took place on Jul 31 ’25, was worth 225,710. In this transaction 10% Owner of this company bought 84,220 shares at a rate of $2.68, taking the stock ownership to the 12,544,220 shares. Before that another transaction happened on Aug 04 ’25, when Company’s 10% Owner bought 780 for $2.83, making the entire transaction worth $2,211. This insider now owns 12,545,000 shares in total.
Codexis Inc (CDXS) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.29 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.08% during the next five years compared to -33.31% drop over the previous five years of trading.
Codexis Inc (NASDAQ: CDXS) Trading Performance Indicators
Here are Codexis Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Codexis Inc (CDXS)
Looking closely at Codexis Inc (NASDAQ: CDXS), its last 5-days average volume was 1.35 million, which is a jump from its year-to-date volume of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 7.18%.
During the past 100 days, Codexis Inc’s (CDXS) raw stochastic average was set at 39.59%, which indicates a significant increase from 0.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.22 in the past 14 days, which was higher than the 0.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.77, while its 200-day Moving Average is $3.37. However, in the short run, Codexis Inc’s stock first resistance to watch stands at $2.81. Second resistance stands at $2.94. The third major resistance level sits at $3.01. If the price goes on to break the first support level at $2.61, it is likely to go to the next support level at $2.54. Now, if the price goes above the second support level, the third support stands at $2.41.
Codexis Inc (NASDAQ: CDXS) Key Stats
With a market capitalization of 241.92 million, the company has a total of 90,267K Shares Outstanding. Currently, annual sales are 59,350 K while annual income is -65,280 K. The company’s previous quarter sales were 15,330 K while its latest quarter income was -13,270 K.
